Trial intelligence / Profile preview

Mechanistic Evaluation of Gabapentin and Opioid Polypharmacy

NCT07846020Phase 2Not yet recruiting

Sponsor
University of Maryland, Baltimore
Start
Jan 2027
Primary completion
Jan 2032
Countries
1
01

Overview

A Phase 2 trial of gabapentin in low back pain (LBP), sponsored by University of Maryland, Baltimore. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

gabapentin
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT07846020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07846020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call